9 studies found for:
"Spinocerebellar ataxia 3"
Display Options
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
|
||||
| 2 | Withdrawn |
Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
|
||||
| 3 | Completed |
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
|
||||
| 4 | Recruiting |
Dalfampridine and Gait in Spinocerebellar Ataxias
|
||||
| 5 | Recruiting |
Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
|
||||
| 6 | Recruiting |
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
|
||||
| 7 | Active, not recruiting |
RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
|
||||
| 8 | Completed |
Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
|
||||
| 9 | Active, not recruiting |
Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases
|
† Indicates status has not been verified in more than two years